Queuing models aren’t simple but offer big potential service improvements
R&D outlays and patents alone don’t effectively measure corporate creativity
Pharma companies less likely to disclose critical drug information than public institutions
Dedicated FDA staff guide companies during design of clinical trials
How to rebalance supply and demand amid today’s chaotic internet traffic
People will endure inconvenience to synchronize events, regardless of proximity
Study finds interest in screening embryos for education propensity, especially if everyone else is doing it
It’s still early days in genetic research, though advances will aid study of educational attainment and, notably, disease
Cellphone signals and patent citations approximate a theory’s long-sought paper trail
Startups lack bench strength, a disadvantage in tight labor markets
Getting the mix right is the goal of a Medicare pilot, which itself could use substantial improvement
Some data shows competing against the platform can help sellers, if not consumers
The risk for matching platforms is affected by levels of fees and what’s disclosed about buyer and seller
Banks close neighborhood outlets and raise prices for branch-delivered services